Loading clinical trials...

UNKNOWNPhase 2NCT01737346

Procarbazine and Lomustine in Recurrent Glioblastoma

The combination therapy of temozolomide and radiation has been established as the standard therapy for the initial treatment of glioblastoma. However, the prognosis for patients with recurrent/ refrac...

Lead sponsor: Incheon St.Mary's Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Dong-Sup Chung, MD

CONTACT

82-32-280-5876 [email protected]

Related studies

Enrolling By InvitationPhase 1

The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM

NCT06616727 · Recurrent Glioblastoma Multiforme (GBM)

COMPLETEDPhase 2

Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme

NCT00883298 · Recurrent Glioblastoma Multiforme, Recurrent Gliosarcoma

COMPLETEDPhase 2

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

NCT00071539 · Recurrent Glioblastoma Multiforme

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 3, 2012Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment52

Start dateOct 2012

Last updatedDec 3, 2012

Condition

Recurrent Glioblastoma Multiforme

Locations shown

Ajou University Hospital

Wonchondong, Suwon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 3, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions